Literature DB >> 22717457

In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients.

Osama M A Ibrahim1, Yukihiro Matsumoto, Murat Dogru, Enrique Sato Adan, Tais Hitomi Wakamatsu, Jun Shimazaki, Hiroshi Fujishima, Kazuo Tsubota.   

Abstract

PURPOSE: To clarify meibomian gland (MG) alterations in atopic keratoconjunctivitis (AKC) patients and compare the findings with obstructive MG dysfunction (MGD) patients and control subjects using in vivo confocal microscopy (CM).
DESIGN: Prospective, controlled, single-center study. PARTICIPANTS: Twelve AKC patients (10 males, 2 females; mean age, 31.0±16.5 years), 12 obstructive MGD patients (7 males, 5 females; mean age, 37.6±5.6 years), and 26 control subjects (13 males, 13 females; mean age, 32.9±5.7 years) were recruited. No significant age or gender differences were observed between the 3 groups.
METHODS: All subjects underwent assessment of tear evaporation rate from the ocular surface (TEROS), slit-lamp examinations, tear break-up time (BUT) measurements, vital staining, Schirmer test I, meibography, MG expressibility, and CM examination of the MG (HRTII-RCM). Statistical analysis was performed using the Mann-Whitney test. MAIN OUTCOME MEASURES: The MG acinar unit density, inflammatory cell density, MG acinar unit longest diameter, MG acinar unit shortest diameter, and MG acinar unit area as observed by in vivo CM, MG drop-out, MG expressibility grading, tear stability, tear evaporation, and vital staining scores.
RESULTS: The TEROS values, mean BUT, vital staining scores, MG expressibility, and MG dropout grades were significantly worse in AKC patients compared with those in obstructive MGD patients and controls (P<0.05). The mean values of the CM parameters in AKC patients were significantly worse than those observed in the obstructive MGD patients and controls (P<0.001).
CONCLUSIONS: Changes in MG in AKC patients seem to be more severe than in patients with obstructive MGD and controls. In vivo CM is a noninvasive, efficient tool in the assessment of MG status and ocular surface disease in AKC.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22717457     DOI: 10.1016/j.ophtha.2012.04.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Eyelid cleansing with ointment for obstructive meibomian gland dysfunction.

Authors:  Minako Kaido; Osama M A Ibrahim; Motoko Kawashima; Reiko Ishida; Enrique A Sato; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2016-10-03       Impact factor: 2.447

Review 2.  Ocular surface inflammation impairs structure and function of meibomian gland.

Authors:  Shin Mizoguchi; Hiroki Iwanishi; Reiko Arita; Kumi Shirai; Takayoshi Sumioka; Masahide Kokado; James V Jester; Shizuya Saika
Journal:  Exp Eye Res       Date:  2017-10       Impact factor: 3.467

Review 3.  [Pathophysiology of atopic blepharokeratoconjunctivitis].

Authors:  T Lapp; P Maier; T Jakob; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

4.  Wide-Field In Vivo Confocal Microscopy of Meibomian Gland Acini and Rete Ridges in the Eyelid Margin.

Authors:  Scott Zhou; Danielle M Robertson
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

5.  In vivo confocal microscopy classification in the diagnosis of meibomian gland dysfunction.

Authors:  Matthieu Randon; Vittoria Aragno; Rachid Abbas; Hong Liang; Antoine Labbé; Christophe Baudouin
Journal:  Eye (Lond)       Date:  2018-12-12       Impact factor: 3.775

6.  The spectrophotometric sulfo-phospho-vanillin assessment of total lipids in human meibomian gland secretions.

Authors:  Anne McMahon; Hua Lu; Igor A Butovich
Journal:  Lipids       Date:  2013-01-24       Impact factor: 1.880

7.  Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice.

Authors:  Nancy J Reyes; Chen Yu; Rose Mathew; Carolina M Kunnen; Joan Kalnitsky; Rachel L Redfern; Andrea Leonardi; Victor L Perez; Amanda S MacLeod; Preeya K Gupta; Daniel R Saban
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

Review 8.  Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.

Authors:  Yureeda Qazi; Shruti Aggarwal; Pedram Hamrah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-04       Impact factor: 3.117

Review 9.  Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease.

Authors:  Yonghoon Lee; Minji Kim; Anat Galor
Journal:  Clin Exp Optom       Date:  2021-08-08       Impact factor: 2.742

10.  In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy.

Authors:  Shengnan Cheng; Yueqi Yu; Jin Chen; Lin Ye; Xinghua Wang; Fagang Jiang
Journal:  BMC Ophthalmol       Date:  2021-06-19       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.